home / stock / xxii / xxii news

XXII News and Press, 22nd Century Group Inc From 11/27/23

Stock Information
Company Name: 22nd Century Group Inc
Stock Symbol: XXII
Market: NYSE
Website: xxiicentury.com
Menu
XXII XXII Quote XXII Short XXII News XXII Articles XXII Message Board
Get XXII Alerts

News, Short Squeeze, Breakout and More Instantly...
XXII - 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has ...
XXII - 22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores

BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has aga...

XXII - 22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License

BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signi...

XXII - Expected earnings - 22nd Century Group Inc

22nd Century Group Inc (XXII) is expected to report $-0.91 for Q3 2023
XXII - 22nd Century GAAP EPS of -$3.68, revenue of $17.8M

2023-11-06 07:39:37 ET More on 22nd Century 22nd Century Group, Inc. (XXII) Q2 2023 Earnings Call Transcript 22nd Century Group prices public offering to raise $5.25M 22nd Century announces proposed public offering Seeking Alpha’s Quant Rating on 22nd ...

XXII - 22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB

BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it supports the ...

XXII - 22nd Century Group reduces its debt

2023-10-25 09:25:27 ET More on 22nd Century 22nd Century Group, Inc. (XXII) Q2 2023 Earnings Call Transcript 22nd Century Group prices public offering to raise $5.25M 22nd Century announces proposed public offering For further details see: 22nd Century Gr...
XXII - 22nd Century Group (XXII) Reduces Debt by $8.1 Million

BUFFALO, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it has reduced t...

XXII - 22nd Century Group prices public offering to raise $5.25M

2023-10-17 09:59:39 ET More on 22nd Century 22nd Century Group Q2 2023 Earnings Call Transcript Updates On 22nd Century Group As Its Stock Rises 87% Post Split 22nd Century announces proposed public offering 22nd Century Group adds 1,200 drug store locations ...

XXII - 22nd Century Announces Pricing of $5.25 Million Public Offering

BUFFALO, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the pri...
Previous 10 Next 10